According to new findings published in Science Translational Medicine, Cleveland Clinic researchers have identified a promising drug target for treating and preventing aggressive, drug-resistant prostate cancer.
Cypriot health authorities on Wednesday advised people aged under 50 to use the Pfizer/BioNTech or Moderna vaccines that are based on the newer, mRNA technology.
Up to half of patients with head and neck squamous cell carcinoma will experience tumor recurrence or new tumors—tumors that often spread and are difficult to […]